- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02010138
Extent of ILM Removal and Its Impact on Outcomes of MH Surgery
Extent of Internal Limiting Membrane Removal and Its Impact on Outcomes of Macular Hole Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This randomized clinical trial was performed at a single center. Patients who were scheduled for surgery for idiopathic macular hole (MH) were enrolled. Eligible patients were equally randomized to small extent group or large extent group depending on the extent of ILM to be removed. Random numbers were generated through computerized block-randomization.
A standard 3-port pars plana vitrectomy was performed by a single surgeon using 23-gauge vitrectomy system, with a 1-step scleral tunnel incision. After posterior vitreous detachment was achieved, peeling of the ILM was performed by an end gripping forceps with the assistance of indocyanine green dye. The ILM was peeled in round shape with the radius of either 0.75-disc diameter or 1.5-disc diameter centering at the center of the MH according to the pre-assigned group. This was followed by a complete fluid-gas exchange, and all patients were encouraged to maintain a face-down position for at least 5 days postoperatively.
Postoperative measurements of BCVA and M-score were conducted at 2- and 6-month follow-up visits by independent masked observers. The first postoperative SD-OCT scanning was usually conducted at 1 to 2 weeks after operation according to the intraocular gas status. Then, OCT scans were conducted at follow-up visits 2, and 6 months postoperatively. The same experienced examiner conducted all the OCT scans on all subjects.
Comparison of anatomical closure, BCVA, M-score, Δ BCVA, and Δ M-score were primarily performed between the two groups. Then, the parameters measured from OCT scans with changes in ETDRS visual acuity and M-score were analyzed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 06315
- Samsung Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- idiopathic macular hole
Exclusion Criteria:
- macular hole associated with other causative diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Small Extent Group (SG)
Patients who were scheduled for surgery for idiopathic macular hole were randomly assigned to the SG.
The small-extent peeling was performed in SG.
|
The internal limiting membrane was peeled in round shape with the radius of 0.75-disc diameter radius (1.5-disc diameter in total) centering at the center of the macular hole.
|
Active Comparator: Large Extent Group (LG)
Patients who were scheduled for surgery for idiopathic macular hole were randomly assigned to the LG.
The large-extent peeling was performed in LG.
|
The internal limiting membrane was peeled in round shape with the radius of 1.5-disc diameter radius (3.0-disc diameter in total) centering at the center of the macular hole.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Degree of foveal elongation
Time Frame: postoperative 6months
|
postoperative 6months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
metamorphopsia
Time Frame: 6months
|
6months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
change in visual acuity
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kunho Bae, MD, Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013-07-083
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Macular Holes
-
Helse Stavanger HFMcGill University; Haukeland University Hospital; Royal Liverpool University... and other collaboratorsNot yet recruitingMacular Holes
-
Oriental Neurosurgery Evidence-Based-Study TeamRecruiting
-
Vienna Institute for Research in Ocular SurgeryCompleted
-
Tianjin Medical UniversityActive, not recruiting
-
Second Affiliated Hospital, School of Medicine,...Unknown
-
Federal University of São PauloUnknown
-
Kyorin UniversityCompleted
-
Fayoum UniversityResearch Institute of Ophthalmology, EgyptRecruiting
-
Minia UniversityRecruiting
-
Faculty Hospital Kralovske VinohradyCharles University, Czech RepublicRecruiting
Clinical Trials on small-extent peeling
-
Wenzhou Medical UniversityUnknown
-
Samsung Medical CenterActive, not recruitingStage IA Non-small Cell Lung CancerKorea, Republic of
-
Jagiellonian UniversityCompleted
-
Rush Eye AssociatesActive, not recruitingDiabetic Retinopathy Visually ThreateningMexico
-
Federal University of São PauloUnknown
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Peking University People's HospitalPeking Union Medical College Hospital; Beijing Tongren Hospital; Beijing HospitalUnknown
-
Peking University People's HospitalCompleted